Cabaletta Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	82.98	163.96	193.24	81.61	122.22
Short-Term Investments	50.62	-	48.01	24.94	-
Cash & Short-Term Investments	133.6	163.96	241.25	106.55	122.22
Cash Growth	-18.52%	-32.04%	126.43%	-12.83%	12.48%
Other Current Assets	5.27	2.71	3.24	2.29	2.32
Total Current Assets	138.87	166.68	244.49	108.83	124.54
Net Property, Plant & Equipment	21.05	16.08	7.45	7.57	1.44
Other Long-Term Assets	5.16	2.29	1.71	0.57	0.36
Total Assets	165.08	185.05	253.65	116.97	126.34
Accounts Payable	6.64	4.92	4.55	2.46	2.33
Accrued Expenses	19.3	12.19	7.89	4.85	6.05
Current Portion of Leases	24.22	9.98	3.56	2.18	-
Total Current Liabilities	50.15	27.09	15.99	9.49	8.38
Long-Term Leases	2.88	5.63	1.46	2.96	-
Total Long-Term Liabilities	2.88	5.63	1.46	2.96	-
Total Liabilities	53.03	32.71	17.45	12.45	8.38
Common Stock	0	0	0	-	-
Additional Paid-in Capital	628.98	501.44	469.4	270.13	230.54
Accumulated Other Comprehensive Income	0.03	-	0.04	-0.05	-
Retained Earnings	-516.96	-349.1	-233.24	-165.56	-112.59
Shareholders' Equity	112.05	152.34	236.2	104.52	117.96
Total Liabilities & Equity	165.08	185.05	253.65	116.97	126.34
Total Debt	27.1	15.6	5.02	5.14	0
Net Cash (Debt)	106.5	148.36	236.23	101.41	122.22
Net Cash Growth	-28.21%	-37.20%	132.95%	-17.03%	12.48%
Net Cash Per Share	1.33	3.00	-	-	4.75
Book Value	112.05	152.34	236.2	104.52	117.96
Book Value Per Share	1.40	3.08	-	-	4.58
Tangible Book Value	112.05	152.34	236.2	104.52	117.96
Tangible Book Value Per Share	1.40	3.08	-	-	4.58

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q